GJMIC.070104

Review

Tumor Microecology: From a Bystander Phenomenon to an Intervenable Therapeutic Niche

 

Xingding Zhang1,* 

1Shenzhen Key Laboraory for Systems Medicine in Inflammatory Diseases, Zhongshan School of Medicine, Sun Yat-sen University Shenzhen Campus, Shenzhen, Guangdong 518107, China

*, Correspondence
Professor Xingding Zhang, Ph.D., Zhongshan School of Medicine, Sun Yat-sen University Shenzhen Campus,Shenzhen, Guangdong 518107, China. E-mail: zhangxd39@mail.sysu.edu.cn
Received: May 25, 2026; Accepted: July 22, 2026; Published online: November 12, 2026.
Cite this paper: Xingding Zhang. Tumor Microecology: From a Bystander Phenomenon to an Intervenable Therapeutic Niche. Global Journal of Microbiology, 2026;7(1):16-23. http://naturescholars.com/gjmic.070104. https://doi.org/10.46633/gjmic.070104.
Copyright © 2026 by Scholars Publishing, LLC

Abstract

The microbiome has emerged as a fundamental modifier of host immunity, metabolism, tissue homeostasis, therapeutic responsiveness and treatment-related toxicity. In oncology, accumulating evidence indicates that microorganisms are not merely passive bystanders or infectious complications, but active ecological determinants of tumor development, immune surveillance, treatment response and adverse events. The concept of tumor microecology extends beyond the gut microbiome and includes intratumoral microorganisms, microbial metabolites, mucosal barrier integrity and tissue-specific immune niches. This Commentary discusses the evolving role of microbial ecosystems in cancer biology, with particular attention to cancer immunotherapy, intratumoral microbiota and hematologic malignancies. We propose that future cancer microbiome research should move from descriptive association studies toward mechanism-defined, clinically actionable ecological interventions. Rather than searching for universal “beneficial bacteria,” the field should focus on microbial functions, host context, longitudinal dynamics, methodological rigor and safety-controlled translational strategies.

Keywords: Tumor microecology; microbiome; cancer immunotherapy; intratumoral microbiota; bone marrow niche; multiple myeloma; microbial metabolites.